CureToday: UC enrolling patients for glioblastoma trial
A new clinical trial at the University of Cincinnati is studying the effectiveness of a new two-pronged immunotherapy treatment procedure to treat the most aggressive and deadly type of brain tumors, called glioblastomas. Originating from healthy brain cells, glioblastomas can form in any area of the brain.
Soma Sengupta, MD, PhD, said the trial will administer two immunotherapy drugs in tandem with each other. She noted previous research has shown a single-arm immunotherapy treatment has not been effective, leading to the combination therapy being tested in the trial.
In collaboration with the Dana-Farber Cancer Insitute in Boston, a teaching affiliate of Harvard Medical School, researchers aim to enroll 24 patients in the Phase 1 study.
For more trial and enrollment information, contact Alex Love at lovea4@ucmail.uc.edu.
Featured photo at top of glioblastoma cells in culture courtesy of National Cancer Institute.
Related Stories
Ohio looks to fast-track wastewater discharge permits
December 16, 2025
Bradford Mank, James B. Helmer Jr. Professor of Law at the University of Cincinnati, spoke with WVXU for a story about a proposal by the Ohio Environmental Protection Agency to streamline the way wastewater discharge permits are issued to data centers.
Tariff troubles for online shoppers
December 16, 2025
This year’s new regulations on tariffs and customs are leaving holiday shoppers with unexpected fees on some of their purchases, according to recent reporting by WLWT. Associate Dean of Impact and Partnerships for the University of Cincinnati’s Lindner College of Business Charles Sox spoke to WLWT about why shoppers are only just now feeling the impact, despite these policies being in effect for months.
Limited IT support offered during winter season days
December 16, 2025
The IT Service Desk, powered by Digital Technology Solutions (DTS), will be closed from Wednesday, Dec. 24, through Thursday, Jan. 1, during the university’s Winter Season Days closure. The Service Desk will resume normal operations Friday, Jan. 2.